Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single vs Dual Antibiotic Therapy for Pediatric Perforated Appendicitis
NCT03289351Phase 4Completed
- Sponsor
- Phoenix Children's
- Start
- May 2017
- Primary completion
- Nov 2021
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of piperacillin + tazobactam in perforated appendicitis, sponsored by Phoenix Children's. Started May 2017; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
perforated appendicitis
Beyond the preview
Go deeper on NCT03289351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03289351.